MRC Agrotech Ltd Approves Quarterly and Annual Financial Results for FY2025-26; Reports Profit of 140.49 Lakhs in Consolidated Entity

MRC Agrotech Ltd Approves Quarterly and Annual Financial Results for FY2025-26; Reports Profit of 140.49 Lakhs in Consolidated Entity

MRC Agrotech Ltd Approves Quarterly and Annual Financial Results for FY2025-26; Reports Profit of 140.49 Lakhs in Consolidated Entity​

MRC Agrotech Limited has announced the audited results for its standalone and consolidated entities for the quarter and financial year ending March 31, 2026. The company's Board of Directors reviewed and approved the results, alongside providing an audit report with unmodified opinion.

The consolidated financial statements reflect the performance of the holding company and its subsidiaries: Agronica Seeds Spark Private Limited (51% shareholding) and MARSAPI Lifesciences Private Limited (100% wholly owned subsidiary).

Financial Highlights for Consolidated Group (FY Ended March 31, 2026)​

The consolidated entity reported robust performance over the fiscal year. Total revenue stood at Rs. 8,988.08 lacs, with other income amounting to Rs. 50.92 lacs. The group recorded total expenses of Rs. 8,849.77 lacs against a total revenue of Rs. 9,039.00 lacs.

The company reported Profit Before Tax (PBT) at Rs. 189.23 lacs. After accounting for tax expenses, the net profit for the period from continuing operations was recorded at Rs. 140.49 lacs.

Key Financial Data Summary (in Lakhs)​

A comparison of the audited results for both the standalone and consolidated entities is provided below:

ParticularMetricStandalone Entity (31-Mar-26)Consolidated Group (31-Mar-26)
Total RevenueLakhs8,545.898,988.08
Other IncomeLakhs50.9250.92
Net Profit from Continuing OperationsLakhs116.55140.49

Balance Sheet Status​

As of March 31, 2026, the consolidated financial statements show a total asset base of Rs. 11,467.51 lacs. Shareholders' funds stood at Rs. 5,334.39 lacs, including Share Capital of Rs. 3,132.74 lacs and Reserves and Surplus of Rs. 2,200.52 lacs.

Operational Updates and Audit Focus​

The audit reports highlighted several key operational activities undertaken during the financial year:

  • Subsidiary Acquisition: The company acquired Marsapi Lifesciences Private Limited (100% subsidiary) during the year through a shareholders agreement dated June 5, 2025. This acquisition was completed on a share-swap basis, where MRC Agrotech issued up to 86,42,097 equity shares at Rs. 19.50 per share.
  • Receivables Assignment: A significant transaction involved the assignment of receivables (loans and advances totaling Rs. 7,30,00,978) to Cicago Commodities Private Limited on a non-recourse basis. This transaction is noted as being at arm's length.

The auditors highlighted several Key Audit Matters related to the core business, which includes trading in fruits and other perishable commodities. These matters included:
  • Evaluating the commercial substance of back-to-back trading transactions, where purchases and sales occurred within short periods.
  • Addressing concentration risk, as two counterparties accounted for approximately 53% of the company's purchases and 23% of its sales during the year.

The audit procedures performed included verification of invoices, e-way bills, and matching quantities across purchase and sales transactions. The auditor noted that while the company recorded exempt sales of Rs. 81.14 crore and export sales of Rs. 0.06 crore in its books, these goods were classified as agricultural commodities exempt under applicable GST notifications.

Stock Price Movement​

MRC Agrotech Ltd. settled on Friday at ₹34.57 after shares shed 2.81% of their value. The stock saw significant intraday movement, registering swings between a high of ₹36.83 and a low of ₹33.82.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top